From RibeirŃo Preto-SP, Brazil:
My nine year old daughter has had type 1 diabetes for six years, and this week I saw that the FDA approved the Sleep Sentry to monitor symptoms of hypoglycemia. Do you have any information about the Sleep Sentry? Do you think this device would be good for children?
The Sleep Sentry is a device that senses nocturnal hypoglycemia on the basis of sweating and lowered skin temperature and does not measure blood glucose directly. The original version was discontinued a number of years ago because of skin sensitivity and the high incidence of false alarms. It has recently been reintroduced with FDA approval, but we have not had any experience with the new version in this center nor could I find any reports of experience in children with this new model.
You can learn more about it on the manufacturer's website, but unless there is some special urgency about monitoring your daughter's night time blood sugars, I would first of all talk to her diabetes doctor about starting her on an insulin regimen of Lantus for basal control and after meal Humalog or NovoLog. Such a change, if it has not already been made, could reduce nocturnal hypoglycemia to a minimum.
In the not too distant future there, will be even better devices for monitoring blood sugar such as the infra-red SugarTrac, the smaller Glucowatch III and indwelling sensors like the DexCom that creates a radio signal to an external monitor.
|Return to the Top of This Page|
Last Updated: Tuesday April 06, 2010 15:09:46
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.